BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST‐LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL). (June 2017) - Gallamini, A.; Bijou, F.; Viotti, J.; Rossi, A.; Perrot, A.; Patti, C.; Gastaud, L.; Sorasio, R.; Debaigt, C.; Chamorey, E.; Viviani, S.; Thyss, A.